Acute idiopathic blind spot enlargement syndrome
Rare eye disease with blind spot enlargement and no known cure.
Acute idiopathic blind spot enlargement syndrome (AIBSE) is a rare eye disease affecting the retina, classified as a type of retinopathy. It primarily involves enlargement of the blind spot in the visual field and acute onset photopsia, and it affects females more than males. The condition was first described by Fletcher et al. in 1988.
- field
- Ophthalmology
- known_for
- Rare retinopathy causing blind spot enlargement and photopsia
- demographics
- Affects females more than males; higher incidence in Caucasian people
- first_described_by
- Fletcher et al. (1988)
- diagnostic_gold_standard
- Optical coherence tomography (OCT)
Lore & Background
AIBSE syndrome is characterized by an acute onset of photopsia and enlargement of the blind spot in the visual field. Other symptoms include monocular scotoma and reduced light perception. The exact cause is unknown, but studies suggest viral illnesses like influenza and vaccinations such as MMR may trigger the condition. Diagnosis involves multiple techniques including ophthalmoscopy, visual field testing, optical coherence tomography (OCT), fluorescein angiography, multifocal electroretinography, and electrophysiology. OCT is considered the gold standard for diagnosis as it reveals microstructural alterations in the outer retina. In early stages, fluorescein angiography may show peripapillary hyperfluorescence.
Reader's Guide
AIBSE syndrome is significant as a rare, self-limiting retinopathy that predominantly affects females and Caucasian individuals. Although there is no specific treatment, the condition usually resolves on its own, though the enlarged blind spot often does not return to normal. Systemic corticosteroids may be advised in some cases. Its recognition by Fletcher et al. in 1988 established a distinct clinical entity that aids in differential diagnosis of visual field defects. The condition's association with viral triggers and vaccinations highlights potential immune-mediated mechanisms, though the exact etiology remains unknown. Its legacy lies in advancing understanding of outer retinal disorders and the importance of OCT in diagnosing microstructural retinal changes.
Did You Know?
- AIBSE syndrome affects females more than males.
- The condition is usually self-limiting, but the enlarged blind spot often does not return to normal.
- Viral illnesses like influenza and vaccinations such as MMR may trigger the condition.
- Optical coherence tomography (OCT) is the gold standard for diagnosing AIBSE syndrome.
Frequently Asked Questions
Who is Acute idiopathic blind spot enlargement syndrome?
AIBSE is a rare retinopathy that targets the macular region of the retina, causing the physiological blind spot in a patient's visual field to widen. It was first formally identified in the medical literature by Fletcher and colleagues in 1988.
What are Acute idiopathic blind spot enlargement syndrome's powers/role?
Its signature effects include an acute expansion of the blind spot and the triggering of photopsia, or sudden flashes of light, in the affected eye. The condition shows a higher incidence among females and within Caucasian populations compared to other demographic groups.
How does Acute idiopathic blind spot enlargement syndrome's story end?
There is currently no known cure, so the condition does not have a definitive resolution in its clinical narrative. Management is limited to monitoring and symptomatic relief rather than a permanent corrective treatment.
Why is Acute idiopathic blind spot enlargement syndrome important?
It serves as a distinct diagnostic entity within the spectrum of retinopathies, helping ophthalmologists separate it from other macular or visual-field disorders. Its rarity, female predominance, and acute onset make it a notable consideration when patients present with sudden blind-spot changes.
How do you confirm Acute idiopathic blind spot enlargement syndrome's identity?
Optical coherence tomography (OCT) is the diagnostic gold standard, allowing clinicians to visualize the structural changes in the retinal layers that characterize the condition. This imaging step helps distinguish AIBSE from other causes of blind-spot enlargement and guides appropriate follow-up.
More in Rare diseases 1-24
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record